Weighted re-randomization tests for minimization with unbalanced allocation

Pharmaceutical Statistics

Volumn 12, Issue 4, 2013, Pages 243-253

  Han, Baoguang ^a   Yu, Menggang ^b   McEntegart, Damian ^c  

^a ELI LILLY AND COMPANY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^c Perceptive Informatics   (United Kingdom)

Author keywords

covariate adaptive randomization; minimization; re randomization test; temporal trend

Indexed keywords

ANALYSIS OF COVARIANCE; ARTICLE; HUMAN; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MONTE CARLO METHOD; RANDOMIZATION; SIMULATION;

COVARIATE-ADAPTIVE RANDOMIZATION; MINIMIZATION; RE-RANDOMIZATION TEST; TEMPORAL TREND;

BIAS (EPIDEMIOLOGY); COMPUTER SIMULATION; DATA INTERPRETATION, STATISTICAL; HUMANS; MODELS, STATISTICAL; PROBABILITY; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RESEARCH DESIGN;

EID: 84880047248     PISSN: 15391604     EISSN: 15391612     Source Type: Journal    
DOI: 10.1002/pst.1577     Document Type: Article

References (24)

1. Rosenberger WL, Lachin JM,. Randomization in Clinical Trial: Theory and Practice. Wiley: New York, 2002.
2. Berger V,. Selection Bias and Covariate Imbalances in Randomized Clinical Trials. Wiley: Chichester, 2005.
3. McEntegart D., The pursuit of balance using stratified and dynamic randomization techniques: an overview. Drug Information Journal 2003; 37: 293-308. DOI: 10.1177/009286150303700305.
4. Kernan WN, Viscoli CM, Makuch RW, Brass LM, Horwitz RI,. Stratified randomization for clinical trials. Journal of Clinical Epidemiology 1999; 52: 19-26. DOI: 10.1016/S0895-4356(98)00138-3.
5. Taves D,. Minimization: a new method of assigning subjects to treatment and control groups. Clinical Pharmacology Therapeutics 1974; 15: 443-453.
6. Pocock SJ, Simon R,. Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 1975; 31: 103-115.
7. Han B, Enas NH, McEntegart D,. Randomization by minimization for unbalanced treatment allocation. Statistics in Medicine 2009; 28: 3329-3346. DOI: 10.1002/sim.3710.
8. Gail M, Williams R, Byar DP, Brown C,. How many controls? Journal of Chronic Diseases 1976; 29: 723-731.
9. Woods SW, Sholomskas DE, Shear MK, Gorman JM, Barlow DH, Goddard AW, Cohen J,. Efficient allocation of patients to treatment cells in clinical trials with more than two treatment conditions. American Journal of Psychiatry 1998; 155: 1446-1448.
10. McEntegart DDR,. Letter to the Editor re Dumville et al Contemp. Clin. Trials, 2006; 27:1-12. Contemporary Clinical Trials 2006; 27: 207-208. DOI: 10.1016/j.cct.2006.02.003.
11. Chen W, Ghosh D, Raghunathan TE, Sargent DJ,. Bayesian variable selection with joint modeling of categorical and survival outcomes: an application to individualizing chemotherapy treatment in advanced colorectal cancer. Biometrics 2009; 65: 1030-1040.
12. Simon R,. Restricted randomization designs in clinical trials. Biometrics 1979; 35: 503-512.
13. Hasegawa T, Tango T,. Permutation test following covariate-adaptive randomization in randomized controlled trials. Journal of Biopharmaceutical Statistics 2009; 19: 106-119. DOI: 10.1080/10543400802527908.
14. Proschan MB, Brittain E, Kammerman L,. Minimize the use of minimization with unequal allocation. Biometrics 2011; 67: 1135-1141. DOI: doi: 10.1111/j.1541-0420.2010.01545.x.
15. van der Ploeg AT, Clemens PR, Corzo D, Escolar DM, Florence J, Groeneveld GJ, Herson S, Kishnani PS, Laforet P, Lake SL, Lange DJ, Leshner RT, Mayhew JE, Morgan C, Nozaki K, Park DJ, Pestronk A, Rosenbloom B, Skrinar A, van Capelle CI, van der Beek NA, Wasserstein M, Zivkovic SA,. A randomized study of alglucosidase alfa in late-onset Pompe's disease. New England Journal of Medicine 2010; 362: 1396-1406. DOI: 10.1056/NEJMoa0909859.
16. FDA. Endocrinologic and Metabolic Drugs Advisory Committee Meeting, 2008. available at: www.fda.gov/dockets/ac/08/transcripts/2008-4389t1-part1.pdf (last accessed June 6, 2013).
17. Ernst M,. Permutation methods: a basis for exact reference. Statistical Sciences 2004; 19: 676-685. DOI: 10.1214/088342304000000396.
18. Shao J, Xinxin Y, Zhong B,. A theory for testing hypotheses under covariate-adaptive randomization. Biometrika 2010; 97: 347-360. DOI: 10.1093/biomet/asq014.
19. Kalish LA, Begg CB,. The impact of treatment allocation procedures on nominal significance levels and bias. Controlled Clinical Trials 1987; 8: 121-135.
20. Efron B,. Forcing a sequential experiment to be balanced. Biometrika 1971; 58: 403-417.
21. Chen Y-P,. Biased coin design with imbalance tolerance. Communication in Statistics-Stochastic Models 15 1999; 15: 953-975.
22. Berger VW,. Pros and cons of permutation tests in clinical trials. Statistics in Medicine 2000; 19: 1319-1328.
23. Lachin JM, Matts JP, Wei LJ,. Randomization in clinical trials: conclusions and recommendations. Control Clinical Trials 1988; 9: 365-374.
24. Kuznetsova OM, Tymofyeyev Y,. Preserving the allocation ratio at every allocation with biased coin randomization and minimization in studies with unequal allocation. Statistics in Medicine 2012; 31: 701-723. DOI: 10.1002/sim.4447.